MX2017014213A - Penicilina-g acilasas. - Google Patents

Penicilina-g acilasas.

Info

Publication number
MX2017014213A
MX2017014213A MX2017014213A MX2017014213A MX2017014213A MX 2017014213 A MX2017014213 A MX 2017014213A MX 2017014213 A MX2017014213 A MX 2017014213A MX 2017014213 A MX2017014213 A MX 2017014213A MX 2017014213 A MX2017014213 A MX 2017014213A
Authority
MX
Mexico
Prior art keywords
enzymes
penicillin
acylases
acylase
pga
Prior art date
Application number
MX2017014213A
Other languages
English (en)
Inventor
Jie Yang
Banerjee Goutami
Zhang Xiyun
M Milczek Erika
Ann Mayo Melissa
JENNE Stephan
Original Assignee
Codexis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Codexis Inc filed Critical Codexis Inc
Publication of MX2017014213A publication Critical patent/MX2017014213A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C12N9/84—Penicillin amidase (3.5.1.11)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
    • C12Y305/01011—Penicillin amidase (3.5.1.11), i.e. penicillin-amidohydrolase

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invención proporciona enzimas diseñadas de penicilina G acilasa (PGA) que tienen propiedades mejoradas, polinucleótidos que codifican dichas enzimas, composiciones que incluyen las enzimas y métodos para usar las enzimas.
MX2017014213A 2015-05-07 2016-05-06 Penicilina-g acilasas. MX2017014213A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562158118P 2015-05-07 2015-05-07
PCT/US2016/031132 WO2016179464A1 (en) 2015-05-07 2016-05-06 Penicillin-g acylases

Publications (1)

Publication Number Publication Date
MX2017014213A true MX2017014213A (es) 2018-03-28

Family

ID=57218075

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017014213A MX2017014213A (es) 2015-05-07 2016-05-06 Penicilina-g acilasas.

Country Status (13)

Country Link
US (5) US9944916B2 (es)
EP (1) EP3292136B1 (es)
JP (1) JP6755886B2 (es)
KR (1) KR102604503B1 (es)
CN (1) CN107531762A (es)
AU (1) AU2016258091B2 (es)
CA (1) CA2983620A1 (es)
DK (1) DK3292136T3 (es)
HU (1) HUE053863T2 (es)
IL (1) IL255245B (es)
MX (1) MX2017014213A (es)
SG (1) SG11201708356PA (es)
WO (1) WO2016179464A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6755886B2 (ja) 2015-05-07 2020-09-16 コデクシス， インコーポレイテッド ペニシリンｇアシラーゼ
US10724025B2 (en) 2016-05-05 2020-07-28 Codexis, Inc. Penicillin-G acylases
KR102696584B1 (ko) * 2017-01-05 2024-08-19 코덱시스, 인코포레이티드 페니실린 ｇ 아실라아제
CA3064577A1 (en) * 2017-06-27 2019-01-03 Codexis, Inc. Penicillin-g acylases
KR101985911B1 (ko) * 2017-12-28 2019-06-04 아미코젠주식회사 Achromobacter sp. CCM 4824 유래 페니실린 G 아실라제 변이체 및 이의 이용
CN109207466B (zh) * 2018-11-08 2021-01-08 山东鲁抗医药股份有限公司 一种青霉素酰化酶的固定化方法及固定化酶
KR102363768B1 (ko) * 2019-11-15 2022-02-16 아미코젠주식회사 세파졸린 생산성이 증가된 페니실린 g 아실라제 변이체 및 이의 이용

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US603344A (en) 1898-05-03 Trough for well-curbs
CA1338400C (en) 1983-08-31 1996-06-18 David H. Gelfand Recombinant fungal cellulases
US6869930B1 (en) 1993-09-17 2005-03-22 Novo Nordisk A/S Acylated insulin
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6995017B1 (en) 1994-02-17 2006-02-07 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6395547B1 (en) 1994-02-17 2002-05-28 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5834252A (en) 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
US6165793A (en) 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6406855B1 (en) 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US5928905A (en) 1995-04-18 1999-07-27 Glaxo Group Limited End-complementary polymerase reaction
US6309883B1 (en) 1994-02-17 2001-10-30 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US20060257890A1 (en) 1996-05-20 2006-11-16 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
CN1192108C (zh) 1994-06-03 2005-03-09 诺沃奇梅兹生物技术有限公司 纯化的毁丝霉属漆酶及编码该酶的核酸
ATE294871T1 (de) 1994-06-30 2005-05-15 Novozymes Biotech Inc Nicht-toxisches, nicht-toxigenes, nicht- pathogenes fusarium expressionssystem und darin zu verwendende promotoren und terminatoren
US5891703A (en) * 1994-08-12 1999-04-06 Gist-Hrocades Mutated penicillin G acylase genes
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US6096548A (en) 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
US6506602B1 (en) 1996-03-25 2003-01-14 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
DK1717322T3 (da) 1997-01-17 2012-10-22 Codexis Mayflower Holdings Llc Udvikling af hele celler og organismer ved rekursiv sekvensrekombination
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
US7148054B2 (en) 1997-01-17 2006-12-12 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
US6365408B1 (en) 1998-06-19 2002-04-02 Maxygen, Inc. Methods of evolving a polynucleotides by mutagenesis and recombination
DE69922978T2 (de) 1998-10-06 2005-12-08 Emalfarb, Mark Aaron, Jupiter Transformationsystem in filamentösen fungiziden chrysosporium-wirtszellen
JP4221100B2 (ja) 1999-01-13 2009-02-12 エルピーダメモリ株式会社 半導体装置
US6917882B2 (en) 1999-01-19 2005-07-12 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US6368861B1 (en) 1999-01-19 2002-04-09 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6436675B1 (en) 1999-09-28 2002-08-20 Maxygen, Inc. Use of codon-varied oligonucleotide synthesis for synthetic shuffling
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
AU3210100A (en) 1999-01-19 2000-08-01 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US7702464B1 (en) 2001-08-21 2010-04-20 Maxygen, Inc. Method and apparatus for codon determining
US7024312B1 (en) 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US6961664B2 (en) 1999-01-19 2005-11-01 Maxygen Methods of populating data structures for use in evolutionary simulations
CA2364997A1 (en) 1999-03-05 2000-09-08 Maxygen, Inc. Encryption of traits using split gene sequences
US7430477B2 (en) 1999-10-12 2008-09-30 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US6519065B1 (en) 1999-11-05 2003-02-11 Jds Fitel Inc. Chromatic dispersion compensation device
WO2001075767A2 (en) 2000-03-30 2001-10-11 Maxygen, Inc. In silico cross-over site selection
US20050084907A1 (en) 2002-03-01 2005-04-21 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
US7747391B2 (en) 2002-03-01 2010-06-29 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
DK2278509T3 (en) 2002-03-01 2014-12-15 Codexis Mayflower Holdings Llc Methods, systems and software for identification of functional biomolecules
US7620500B2 (en) 2002-03-09 2009-11-17 Maxygen, Inc. Optimization of crossover points for directed evolution
SI1648933T1 (sl) 2003-07-25 2010-01-29 Conjuchem Biotechnologies Inc Dolgo delujoäś inzulinski derivat in metoda zanj
US7629157B2 (en) 2003-08-11 2009-12-08 Codexis, Inc. Ketoreductase polypeptides and related polynucleotides
US20090312196A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
US8383346B2 (en) 2008-06-13 2013-02-26 Codexis, Inc. Combined automated parallel synthesis of polynucleotide variants
WO2009152336A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
US8247192B2 (en) 2008-11-10 2012-08-21 Codexis, Inc. Penicillin-G acylases
EP2367940B1 (en) * 2008-12-23 2017-11-22 DSM Sinochem Pharmaceuticals Netherlands B.V. Mutant penicillin G acylases
CN103074320B (zh) * 2012-05-25 2018-06-08 石药集团中奇制药技术（石家庄）有限公司 含有一个或几个点突变的青霉素g酰化酶
JP6755886B2 (ja) 2015-05-07 2020-09-16 コデクシス， インコーポレイテッド ペニシリンｇアシラーゼ

Also Published As

Publication number Publication date
CA2983620A1 (en) 2016-11-10
US20160326508A1 (en) 2016-11-10
US10400231B2 (en) 2019-09-03
US20190345474A1 (en) 2019-11-14
US20180201919A1 (en) 2018-07-19
US10781436B2 (en) 2020-09-22
JP6755886B2 (ja) 2020-09-16
IL255245A0 (en) 2017-12-31
EP3292136A4 (en) 2019-04-10
US11180747B2 (en) 2021-11-23
EP3292136B1 (en) 2021-02-17
AU2016258091B2 (en) 2020-10-01
US20200385699A1 (en) 2020-12-10
DK3292136T3 (da) 2021-03-22
IL255245B (en) 2020-03-31
US9944916B2 (en) 2018-04-17
JP2018515089A (ja) 2018-06-14
SG11201708356PA (en) 2017-11-29
CN107531762A (zh) 2018-01-02
KR20180004169A (ko) 2018-01-10
HUE053863T2 (hu) 2021-07-28
NZ736220A (en) 2024-03-22
WO2016179464A1 (en) 2016-11-10
AU2016258091A1 (en) 2017-11-02
US20220042004A1 (en) 2022-02-10
EP3292136A1 (en) 2018-03-14
KR102604503B1 (ko) 2023-11-20

Similar Documents

Publication Publication Date Title
MX2017014213A (es) Penicilina-g acilasas.
PH12018500950A1 (en) Subcutaneous formulations of anti-cd38 antibodies and their uses
PH12019500540A1 (en) Anti-pd-1 antibodies and their uses
PH12018502456A1 (en) Anti-cd04 antibodies and their uses
MX2020009461A (es) Anticuerpos anti-proteína que contiene dominio de inmunologlubina rfig elacionado con el receptor de poliovirus (pvrig) y métodos de uso.
EP3585379A4 (en) CYCLIC DINUCLEOTIDES AS AGONISTS OF THE STIMULATOR OF INTERFERON-DEPENDENT SIGNALING
MX2016013668A (es) Inhibidores de cinasas asociadas al receptor de interleucina-1 (irak) y usos de los mismos.
ZA201902141B (en) Acid-alpha glucosidase variants and uses thereof
EP3741849A3 (en) Protease variants and polynucleotides encoding same
MX2018008051A (es) Variantes de beta-glucanasa y polinucleotidos que las codifican.
MX2024004419A (es) Variantes de alfa-glucosidasa acida y usos de las mismas.
AU2017317563A8 (en) Detergent compositions comprising xanthan lyase variants I
MX2017009937A (es) Cepas fungicas y metodos de uso.
MX2021014663A (es) Il-23a y tnf-alfa orientados y compuesto y sus usos.
EP3714042A4 (en) USE AND PRODUCTION OF MODIFIED IMMUNE CELLS
MX2017011223A (es) Variantes de protoxina ii y metodos de uso.
MX2017012654A (es) Variantes de protoxina-ii y metodos de uso.
PH12018502233A1 (en) ErbB INHIBITORS AND USES THEREOF
MX2019008096A (es) Penicilina g acilasas.
MX2018013259A (es) Penicilina g acilasas.
WO2010054319A3 (en) Penicillin-g acylases
MX2017014890A (es) Metodos de produccion de acetolactato-descarboxilasa (aldc).
MX2019014861A (es) Compuestos de quinolinilciclohexilpropanamida sustituidos y metodos mejorados para su preparacion.
MX2023009432A (es) Metodo para crear un compuesto a base de mercurio, compuesto a base de mercurio, metodos de uso del compuesto a base de mercurio y usos del compuesto a base de mercurio.
MX2020002682A (es) Metodos de dosificacion intranasal de metoclopramida.